BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
CAPS Rating:
A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.
RSS Headlines
Fool UK
Recs
BDSI has been sucking investors in with their Onsolis diskettes for phentonyl.The date keeps moving back as the price continues to slide back to where it started.This isthe 2nd attempt by the same hedge fund to squeeze slowly the Onsolis approval rumor.I for one will not be had a second time with the same trick by the same hedge fund
You called it